JP7370662B1 - ゲル皮膜及び経口固形組成物 - Google Patents

ゲル皮膜及び経口固形組成物 Download PDF

Info

Publication number
JP7370662B1
JP7370662B1 JP2023537423A JP2023537423A JP7370662B1 JP 7370662 B1 JP7370662 B1 JP 7370662B1 JP 2023537423 A JP2023537423 A JP 2023537423A JP 2023537423 A JP2023537423 A JP 2023537423A JP 7370662 B1 JP7370662 B1 JP 7370662B1
Authority
JP
Japan
Prior art keywords
mass
gel film
oral solid
gel
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023537423A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023228766A1 (https=
JPWO2023228766A5 (https=
Inventor
宏樹 新垣
翔太 浅井
史恭 谷口
順也 山下
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KYOWA Pharmaceutical Industry Co.,Ltd.
Original Assignee
KYOWA Pharmaceutical Industry Co.,Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KYOWA Pharmaceutical Industry Co.,Ltd. filed Critical KYOWA Pharmaceutical Industry Co.,Ltd.
Priority claimed from PCT/JP2023/017747 external-priority patent/WO2023228766A1/ja
Priority to JP2023176052A priority Critical patent/JP2023172976A/ja
Application granted granted Critical
Publication of JP7370662B1 publication Critical patent/JP7370662B1/ja
Publication of JPWO2023228766A1 publication Critical patent/JPWO2023228766A1/ja
Publication of JPWO2023228766A5 publication Critical patent/JPWO2023228766A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2023537423A 2022-05-23 2023-05-11 ゲル皮膜及び経口固形組成物 Active JP7370662B1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023176052A JP2023172976A (ja) 2022-05-23 2023-10-11 ゲル皮膜及び経口固形組成物

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP2022084151 2022-05-23
JP2022084151 2022-05-23
JP2023072747 2023-04-26
JP2023072749 2023-04-26
JP2023072748 2023-04-26
JP2023072749 2023-04-26
JP2023072748 2023-04-26
JP2023072747 2023-04-26
PCT/JP2023/017747 WO2023228766A1 (ja) 2022-05-23 2023-05-11 ゲル皮膜及び経口固形組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023176052A Division JP2023172976A (ja) 2022-05-23 2023-10-11 ゲル皮膜及び経口固形組成物

Publications (3)

Publication Number Publication Date
JP7370662B1 true JP7370662B1 (ja) 2023-10-30
JPWO2023228766A1 JPWO2023228766A1 (https=) 2023-11-30
JPWO2023228766A5 JPWO2023228766A5 (https=) 2024-05-09

Family

ID=88510041

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023537423A Active JP7370662B1 (ja) 2022-05-23 2023-05-11 ゲル皮膜及び経口固形組成物
JP2023176052A Pending JP2023172976A (ja) 2022-05-23 2023-10-11 ゲル皮膜及び経口固形組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023176052A Pending JP2023172976A (ja) 2022-05-23 2023-10-11 ゲル皮膜及び経口固形組成物

Country Status (4)

Country Link
US (1) US20240307314A1 (https=)
EP (1) EP4529923A4 (https=)
JP (2) JP7370662B1 (https=)
KR (1) KR20250012498A (https=)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10500973A (ja) * 1994-06-07 1998-01-27 エルティエス ローマン テラピイ−システム ジイエムビイエイチ 特に経口適用のための、活性物質担体として適している体積膨脹可能なシート状の適用形態
JP2009007379A (ja) * 2001-04-24 2009-01-15 Lintec Corp 経口投与剤及び経口投与剤保持体
JP2014189548A (ja) * 2013-03-28 2014-10-06 Lintec Corp 嚥下物被覆体
JP6964369B1 (ja) * 2021-02-10 2021-11-10 共和薬品工業株式会社 速崩壊性ゲル皮膜

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61161215A (ja) 1985-01-08 1986-07-21 Showa Denko Kk 固形物の易嚥下化処理法
GB8702411D0 (en) 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
DE59702733D1 (de) 1996-08-15 2001-01-11 Losan Pharma Gmbh Gut schluckbare orale arzneiform
JP5326401B2 (ja) * 2007-08-31 2013-10-30 大正製薬株式会社 エリスリトール配合糖衣液
US10042967B2 (en) 2015-11-16 2018-08-07 Taiwan Semiconductor Manufacturing Co., Ltd. Electromigration sign-off methodology
WO2019186386A1 (en) * 2018-03-29 2019-10-03 Azista Industries Pvt Ltd Melatonin oral dissolving film

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10500973A (ja) * 1994-06-07 1998-01-27 エルティエス ローマン テラピイ−システム ジイエムビイエイチ 特に経口適用のための、活性物質担体として適している体積膨脹可能なシート状の適用形態
JP2009007379A (ja) * 2001-04-24 2009-01-15 Lintec Corp 経口投与剤及び経口投与剤保持体
JP2014189548A (ja) * 2013-03-28 2014-10-06 Lintec Corp 嚥下物被覆体
JP6964369B1 (ja) * 2021-02-10 2021-11-10 共和薬品工業株式会社 速崩壊性ゲル皮膜

Also Published As

Publication number Publication date
US20240307314A1 (en) 2024-09-19
EP4529923A4 (en) 2025-09-17
JPWO2023228766A1 (https=) 2023-11-30
EP4529923A1 (en) 2025-04-02
KR20250012498A (ko) 2025-01-24
JP2023172976A (ja) 2023-12-06

Similar Documents

Publication Publication Date Title
JP6092936B2 (ja) 口腔内崩壊錠の製造方法
JP6521564B2 (ja) 速崩性の固体被覆剤形
JP2004277426A (ja) スクラロース含有組成物
TW201124176A (en) Compressible-coated pharmaceutical compositions and tablets and methods of manufacture
JP2010248106A (ja) フィルムコーティング錠
WO2012147873A1 (ja) 口腔内崩壊性に優れたコーティング組成物
WO2015122477A1 (ja) フィルムコーティングされた口腔内崩壊錠
JP2025179197A (ja) イブプロフェンとトラネキサム酸を含有する錠剤及びその製造方法
JP2002255796A (ja) 口腔内速崩壊型錠剤及びその製造方法
JP6964369B1 (ja) 速崩壊性ゲル皮膜
JP7370662B1 (ja) ゲル皮膜及び経口固形組成物
JP2005139085A (ja) 顆粒
JP2019081757A (ja) 固形製剤の製造方法
JP2008094845A (ja) 医薬錠剤
WO2023228766A1 (ja) ゲル皮膜及び経口固形組成物
JP2021138689A (ja) 錠剤、その製造方法、および医薬品
JP7750663B2 (ja) 被覆固形医薬製剤
CN117440830A (zh) 凝胶膜和口服固体组合物
JP7720770B2 (ja) ロキソプロフェンとグリシンを含有する固形製剤及びその製造方法
JP7023186B2 (ja) 認知症治療薬を含有する口腔内崩壊性錠剤
JP7642026B2 (ja) 腸溶性製剤
JP2014028804A (ja) フェキソフェナジン顆粒製剤及びその製造方法
JP2026044245A (ja) 固形組成物
WO2025197962A1 (ja) 固形製剤および医薬品
EP3398587B1 (en) Compacted pharmaceutical preparation

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230622

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230622

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20230622

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230807

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230808

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230818

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230913

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231011

R150 Certificate of patent or registration of utility model

Ref document number: 7370662

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150